49 related articles for article (PubMed ID: 8477802)
1. Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal.
Suzuki H; Yasukawa K; Saito T; Narazaki M; Hasegawa A; Taga T; Kishimoto T
Eur J Immunol; 1993 May; 23(5):1078-82. PubMed ID: 8477802
[TBL] [Abstract][Full Text] [Related]
2. Oocyte cumulus complex quality and oviduct transportation velocity in systemic autoimmune disease model mice.
Hosotani M; Ichii O; Watanabe T; Kon Y
Exp Biol Med (Maywood); 2023 Aug; 248(16):1359-1363. PubMed ID: 36961243
[TBL] [Abstract][Full Text] [Related]
3. Increased Soluble Interleukin 6 Receptors in Fabry Disease.
Lenzini L; Iori E; Vettore M; Gugelmo G; Radu C; Padoan A; Carraro G; Simioni P; Calò L; Avogaro A; Rossi GP; Vitturi N
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202225
[TBL] [Abstract][Full Text] [Related]
4. From Systemic Inflammation to Neuroinflammation: The Case of Neurolupus.
Bendorius M; Po C; Muller S; Jeltsch-David H
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428632
[TBL] [Abstract][Full Text] [Related]
5. Re-Examining Neutrophil Participation in GN.
Caster DJ; Powell DW; Miralda I; Ward RA; McLeish KR
J Am Soc Nephrol; 2017 Aug; 28(8):2275-2289. PubMed ID: 28620081
[TBL] [Abstract][Full Text] [Related]
6. From the Cover: Interplay Between IFN-γ and IL-6 Impacts the Inflammatory Response and Expression of Interferon-Regulated Genes in Environmental-Induced Autoimmunity.
Cauvi DM; Cauvi G; Toomey CB; Jacquinet E; Pollard KM
Toxicol Sci; 2017 Jul; 158(1):227-239. PubMed ID: 28453771
[TBL] [Abstract][Full Text] [Related]
7. CD74 Deficiency Mitigates Systemic Lupus Erythematosus-like Autoimmunity and Pathological Findings in Mice.
Zhou Y; Chen H; Liu L; Yu X; Sukhova GK; Yang M; Zhang L; Kyttaris VC; Tsokos GC; Stillman IE; Ichimura T; Bonventre JV; Libby P; Shi GP
J Immunol; 2017 Apr; 198(7):2568-2577. PubMed ID: 28219888
[TBL] [Abstract][Full Text] [Related]
8. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 6 Accelerates Mortality by Promoting the Progression of the Systemic Lupus Erythematosus-Like Disease of BXSB.Yaa Mice.
Jain S; Park G; Sproule TJ; Christianson GJ; Leeth CM; Wang H; Roopenian DC; Morse HC
PLoS One; 2016; 11(4):e0153059. PubMed ID: 27050763
[TBL] [Abstract][Full Text] [Related]
10. IL-6 blockade in chronic inflammatory diseases.
Puchner A; Blüml S
Wien Med Wochenschr; 2015 Jan; 165(1-2):14-22. PubMed ID: 25335457
[TBL] [Abstract][Full Text] [Related]
11. Upregulated expression level of the growth factor, progranulin, is associated with the development of primary Sjögren's syndrome.
Zhang N; Yang N; Chen Q; Qiu F; Li X
Exp Ther Med; 2014 Nov; 8(5):1643-1647. PubMed ID: 25289074
[TBL] [Abstract][Full Text] [Related]
12. Expression level of the growth factor progranulin is related with development of systemic lupus erythematosus.
Qiu F; Song L; Ding F; Liu H; Shu Q; Yang N; Liu W; Li X
Diagn Pathol; 2013 May; 8():88. PubMed ID: 23702100
[TBL] [Abstract][Full Text] [Related]
13. Novel treatments for systemic lupus erythematosus.
Xiong W; Lahita RG
Ther Adv Musculoskelet Dis; 2011 Oct; 3(5):255-66. PubMed ID: 22870484
[TBL] [Abstract][Full Text] [Related]
14. Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE.
Su DL; Lu ZM; Shen MN; Li X; Sun LY
J Biomed Biotechnol; 2012; 2012():347141. PubMed ID: 22500087
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions.
Ogata A; Tanaka T
Int J Rheumatol; 2012; 2012():946048. PubMed ID: 22315615
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory cytokines in systemic lupus erythematosus.
Ohl K; Tenbrock K
J Biomed Biotechnol; 2011; 2011():432595. PubMed ID: 22028588
[TBL] [Abstract][Full Text] [Related]
17. The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.
Gulinello M; Putterman C
J Biomed Biotechnol; 2011; 2011():207504. PubMed ID: 21331367
[TBL] [Abstract][Full Text] [Related]
18. Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances.
Yap DY; Lai KN
J Biomed Biotechnol; 2010; 2010():365083. PubMed ID: 20467470
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.
Illei GG; Shirota Y; Yarboro CH; Daruwalla J; Tackey E; Takada K; Fleisher T; Balow JE; Lipsky PE
Arthritis Rheum; 2010 Feb; 62(2):542-52. PubMed ID: 20112381
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-6, soluble interleukin-6 receptor and Crohn's disease activity.
Nancey S; Hamzaoui N; Moussata D; Graber I; Bienvenu J; Flourie B
Dig Dis Sci; 2008 Jan; 53(1):242-7. PubMed ID: 17549633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
